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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
23.06.2020 The 
prevalence of 
symptoms in 
24,410 adults 
infected by 
the novel 
coronavirus 
(SARS-CoV-
2; COVID-
19): a 
systematic 
review and 
meta-
analysis of 
148 studies 
from 9 
countries 
PLoS ONE | 
Article 
 Study confirms ‘classic’ 
symptoms of adults 
infected with SARS-CoV-
2 – a persistent cough 
and fever as the most 
prevalent symptoms 
associated with C19 with 
other major symptoms 
including fatigue, losing 
the ability to small and 
difficulty in breathing 
 This study ratifies the list 
of symptoms listed by the 
WHO at the start of the 
pandemic 
 However, there is a large 
proportion of infected 
adults which symptoms 
alone do not identify 
symptoms 
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Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
21.06.2020 Modelling 
the 
pandemic: 
attuning 
models to 
their 
context 
BMJ Global 
Health | 
Analysis 
 Mathematical models 
produce evidence to inform 
policy decisions but 
sociological and 
anthropological work shows 
how these models do not 
always fit with local 
implementation 
 This study draws on cases 
of Ebola and influenza to 
map how sociological and 
anthropological research 
contributes in the modelling 
of pandemics to consider 
lessons for C19 
Modelling, 
sociology, 
anthropology, 
context 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
25.06.2020 Antibody 
tests for 
identification 
of current 
and past 
infection 
with SARS-
CoV-2 
Cochrane SR 
- Diagnostic 
 The sensitivity of antibody tests 
is too low in the first week 
since symptom onset to have a 
primary role for the diagnosis 
of C19 
 But may still have a role with 
other testing in individuals 
presenting later when RT-PCR 
tests are negative or not done 
 Antibody tests are likely to be 
useful for detecting previous 
SARS-CoV-2 infection if used 
15 or more days after onset of 
symptoms 
 However, duration of antibody 
rises remains unknown, with 
little data beyond 35 days post-
symptom onset  
 Authors are therefore uncertain 
about the utility of these tests 
for seroprevalence surveys for 
reasons of public health 
management 
 It is likely that the accuracy of 
tests when used in clinical care 
Antibody 
tests 
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will be lower than reported in 
the included studies 
 It remains unclear whether 
tests are able to detect lower 
antibody levels likely seen with 
milder and asymptomatic C19 
disease given sensitivity has 
mainly been evaluated in 
hospitalised patients 
 Authors highlight that the 
design, execution and 
reporting of studies of the 
accuracy of C19 tests requires 
‘considerable improvement’ 
 Studies must report data on 
sensitivity disaggregated by 
time since onset of symptoms, 
C19 RT-PCR-positive and 
negative cases within WHO 
case definitions 
 All results of test evaluations 
must be made available in the 
public domain to prevent 
selective reporting 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
24.06.2020 Tocilizumab 
in patients 
with severe 
COVID-19: a 
retrospective 
cohort study 
The Lancet 
Rheumatology 
| Article 
 This multi-centre, 
retrospective, 
observational cohort study 
of 544 adults with severe 
C19 pneumonia in Italy, 
found that treatment with 
tocilizumab, whether 
administered intravenously 
or subcutaneously, might 
reduce the risk of invasive 
mechanical ventilation or 
death in patients with 
severe C19 pneumonia  
 Severe 
C19, 
tocilizumab 
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Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
24.06.2020 Mitigating the 
impact of 
COVID-19 on 
countries 
affected by 
HIV, 
tuberculosis 
and malaria 
Global Fund | 
Report 
 Analyses from 
WHO, UNAIDS and 
the Stop TB 
Partnership and 
others suggest the 
annual death toll 
across HIV, TB and 
malaria could nearly 
double, wiping out 
years of progress 
 This report 
estimates that 
countries affected 
by HIV, TB and 
malaria urgently 
needs US$28.5 
billion to protect 
progress made in 
the fight against 
these diseases 
TB, HIV, 
malaria 
 24.06.2020 Voices from 
the frontline: 
findings from 
a thematic 
analysis of a 
rapid online 
global survey 
of maternal 
and newborn 
health 
professionals 
facing the 
COVID-19 
pandemic 
 BMJ Global 
Health | 
Article 
 Analysis from 714 
maternal and 
newborn health 
professionals 
 Findings show a 
substantial 
knowledge gaps 
exist in guidance in 
management of 
maternity cases 
with or without 
COVID-19 
 Levels of stress 
increased among 
health professionals 
globally due to a 
change in working 
hours, difficulties in 
getting to work and 
staff shortages 
 Health 
professionals are 
worried about the 
Health 
professionals, 
maternal and 
newborn 
health 
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impact on health 
outcomes e.g. 
reduced access to 
antenatal care, 
shorter length of 
stay in facilities 
after birth 
 Authors 
recommend that 
formal information-
sharing channels 
for providers be 
established and 
mental health 
support provided 
 This study highlights 
the susceptibility of 
maternity care 
services to 
emergencies, including 
reversal of hard-won 
gains 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
July 2020 Stigma during the COVID-19 pandemic The Lancet 
Infectious 
Diseases | 
Newsdesk 
Sanjeet Bagcchi 
July 2020 COVID-19 in Iran: round 2 The Lancet 
Infectious 
Diseases | 
Newsdesk 
Priya 
Venkatesan 
24.06.2020 Exclusive: Women, babies at risk as 
COVID-19 disrupts health services, World 
Bank warns 
Reuters | News Kate Kelland 
24.06.2020 Why covid-19 antibody tests are not the 
game changer the UK government claims 
BMJ | Feature  
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15.06.2020 Power and politics: the case for linking 
resilience to health system governance 
BMJ Global 
Health | 
Editorial 
Stephanie M 
Topp 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Cochrane       
7 
Response 
Portal 
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
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WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
JAMA 
Network 
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
9 
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
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Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
26.06.2020 
0900 to 
1030 EDT 
Monitoring and 
mitigating the 
collateral effects of 
COVID-19 
Online event 1h 30 CGD 
13 July 3:00 
PM – 6:00 
PM BST 
2020 UCL-Lancet 
Lecture: Global 
Health Preparedness 
by Dr Muhammad 
Pate, Global Director 
for Health, Nutrition 
and Population at the 
World Bank Group 
Online Lecture  2 hour 
lecture, 1 
hour panel 
discussion 
UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership 
role in COVID-19 
vaccine development 
and access 
Zoom webinar   African Union & Africa 
CDC 
Available 
now 
Standard 
precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 
Johns Hopkins School 
of Nursing 
11 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, 
Modelling and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed 
Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
12 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple self-
paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel 
Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple self-
paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
